APA (7th ed.) Citation

Thieme, E., Bruss, N., Sun, D., Dominguez, E. C., Coleman, D., Liu, T., . . . Danilov, A. V. (2023). CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma. Molecular Cancer, 22(1), 1. https://doi.org/10.1186/s12943-023-01762-6

Chicago Style (17th ed.) Citation

Thieme, Elana, et al. "CDK9 Inhibition Induces Epigenetic Reprogramming Revealing Strategies to Circumvent Resistance in Lymphoma." Molecular Cancer 22, no. 1 (2023): 1. https://doi.org/10.1186/s12943-023-01762-6.

MLA (9th ed.) Citation

Thieme, Elana, et al. "CDK9 Inhibition Induces Epigenetic Reprogramming Revealing Strategies to Circumvent Resistance in Lymphoma." Molecular Cancer, vol. 22, no. 1, 2023, p. 1, https://doi.org/10.1186/s12943-023-01762-6.